Improved Glycemic Control Following Transition to Tubeless Insulin Pump Therapy in Adults With Type 1 Diabetes

Continuous subcutaneous insulin infusion (CSII) treatment may improve long-term glycemic outcomes and enhance quality of life compared with a multiple daily injection (MDI) insulin regimen for people with type 1 diabetes. As the number of people treated with CSII via a tubeless insulin pump is incre...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Clin Diabetes
Главные авторы: Mehta, Sanjeev N., Tinsley, Liane J., Kruger, Davida, Bode, Bruce, Layne, Jennifer E., Huyett, Lauren M., Dryga, Kate, Dumais, Bonnie, Ly, Trang T., Laffel, Lori M.
Формат: Artigo
Язык:Inglês
Опубликовано: American Diabetes Association 2021
Предметы:
Feature Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7839599/
https://ncbi.nlm.nih.gov/pubmed/33551556
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/cd20-0022
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы